Cargando…

Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis

Rheumatoid arthritis patients have been treated with disease modifying anti-rheumatic drugs (DMARDs) and the newer biologic drugs. We sought to compare and rank the biologics with respect to efficacy. We performed a literature search identifying 54 publications encompassing 9 biologics. We conducted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tvete, Ingunn Fride, Natvig, Bent, Gåsemyr, Jørund, Meland, Nils, Røine, Marianne, Klemp, Marianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565694/ https://www.ncbi.nlm.nih.gov/pubmed/26356639 http://dx.doi.org/10.1371/journal.pone.0137258

Ejemplares similares

Correction: Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis
por: Tvete, Ingunn Fride, et al.
Publicado: (2016)

Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis
por: Binde, Caroline D., et al.
Publicado: (2020)

Does atenolol differ from other β-adrenergic blockers?
por: Aursnes, Ivar, et al.
Publicado: (2007)

Even more suicide attempts in clinical trials with paroxetine randomised against placebo
por: Aursnes, Ivar, et al.
Publicado: (2006)

Suicide attempts in clinical trials with paroxetine randomised against placebo
por: Aursnes, Ivar, et al.
Publicado: (2005)

Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors
por: Binde, Caroline D., et al.
Publicado: (2021)

Risk factors for excessive benzodiazepine use in a working age population: a nationwide 5-year survey in Norway
por: Fride Tvete, Ingunn, et al.
Publicado: (2015)

Mental Health and Disability Pension Onset: Changes in Consumption of Antianxiety and Hypnotic Drugs
por: Tvete, Ingunn Fride, et al.
Publicado: (2018)

A 3-year survey quantifying the risk of dose escalation of benzodiazepines and congeners to identify risk factors to aid doctors to more rationale prescribing
por: Tvete, Ingunn Fride, et al.
Publicado: (2013)

A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants
por: Halvorsen, Sigrun, et al.
Publicado: (2017)

Effects of Biologic Agents in Patients with Rheumatoid Arthritis and Amyloidosis Treated with Hemodialysis
por: Kuroda, Takeshi, et al.
Publicado: (2016)

Parkinson’s disease, treatment choice and survival over time
por: Tvete, I.F., et al.
Publicado: (2022)

Damage progression in rheumatoid arthritis: the role of biologic agents
por: Favalli, Ennio Giulio
Publicado: (2012)

Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan
por: Mahlich, Jörg, et al.
Publicado: (2016)

What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis
por: Messelink, Marianne A, et al.
Publicado: (2023)

Biologic agents for rheumatoid arthritis—negotiating the NICE technology appraisals
por: Kiely, Patrick D. W., et al.
Publicado: (2012)

Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis
por: Pallio, Giovanni, et al.
Publicado: (2020)

Biologic Agents in Rheumatoid Arthritis: An Update for Managed Care Professionals
por: Agarwal, Sandeep K.
Publicado: (2011)

Patient-reported fatigue in patients with rheumatoid arthritis who commence biologic therapy: a longitudinal study
por: Rinke, Hege Selheim, et al.
Publicado: (2019)

Long-Term Efficacy of Rehabilitation Following Arthroscopic Synovectomy in Patients With Rheumatoid Arthritis Treated With Biologic Agents
por: Kanbe, Katsuaki, et al.
Publicado: (2017)

Cell-cell interactions in synovitis: Antigen presenting cells and T cell interaction in rheumatoid arthritis
por: Aarvak, Tanja, et al.
Publicado: (2001)

Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
por: Mishra, Richa, et al.
Publicado: (2009)

Dopaminergic Agents in Rheumatoid Arthritis
por: Capellino, Silvia
Publicado: (2019)

Research on Liver Damage Caused by the Treatment of Rheumatoid Arthritis with Novel Biological Agents or Targeted Agents
por: Zhao, Xin, et al.
Publicado: (2023)

Prediction Aided Tapering In rheumatoid arthritis patients treated with biOlogicals (PATIO): protocol for a randomized controlled trial
por: Messelink, Marianne A., et al.
Publicado: (2022)

Thyroid Autoimmunity and Function after Treatment with Biological Antirheumatic Agents in Rheumatoid Arthritis
por: Bliddal, Sofie, et al.
Publicado: (2017)

A Multiple Treatment Comparison of Eleven Disease-Modifying Drugs Used for Multiple Sclerosis
por: Hamidi, Vida, et al.
Publicado: (2018)

Using LASSO Regression to Predict Rheumatoid Arthritis Treatment Efficacy
por: Odgers, David J., et al.
Publicado: (2016)

Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000)

Biologic TNF inhibiting agents for treatment of rheumatoid arthritis: persistence and dosing patterns in Germany
por: Neubauer, Sarah, et al.
Publicado: (2014)

Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics
por: Takahashi, Kengo, et al.
Publicado: (2015)

New benzodiazepine and Z-hypnotic users and disability pension: an eight-year nationwide observational follow-up study
por: Tvete, Ingunn F., et al.
Publicado: (2017)

Ceria-based nanotheranostic agent for rheumatoid arthritis
por: Kalashnikova, Irina, et al.
Publicado: (2020)

Biologic monotherapy in the treatment of rheumatoid arthritis
por: Detert, Jacqueline, et al.
Publicado: (2015)

Biologicals in rheumatoid arthritis: current and future
por: Avci, Ali Berkant, et al.
Publicado: (2015)

Treatment with Biologicals in Rheumatoid Arthritis: An Overview
por: Rein, Philipp, et al.
Publicado: (2017)

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
por: Takacs, Peter, et al.
Publicado: (2019)

Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2018)

Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study
por: Ogale, Sarika, et al.
Publicado: (2011)

Preferences of patients and health professionals for route and frequency of administration of biologic agents in the treatment of rheumatoid arthritis
por: Huynh, Tuan Khai, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e2qt5pcfs9cvhtqssshuo02qqb